Seminars in Oncology
Volume 29, Issue 3 , Pages 294-300, June 2002

Regulatory issues in tumor marker development☆☆☆

Division of Clinical Laboratory Devices, Office of Device Evaluation, Center for Devices and Radiological Health, Food and Drug Administration, Rockville, MD.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ Address reprint requests to Steven Gutman, MD, MBA, Division of Clinical Laboratory Devices, Food and Drug Administration, HFZ-440, 2098 Gaither Rd, Rockville, MD 20850.

☆☆ This is a US government work. There are no restrictions on its use.

PII: S0093-7754(02)50186-X

doi:10.1053/sonc.2002.33140

Seminars in Oncology
Volume 29, Issue 3 , Pages 294-300, June 2002

Article Tools